Giovanni Barosi

发表

PHP26 CLASSIFICATION AND REGRESSION TREES HELP IN DEVELOPING EMBEDDED EVIDENCEAND CONSENSUS-BASED GUIDELINES

Monia Marchetti, Giovanni Barosi, Sante Tura, 2002 .

A Knowledge System Architecture for Diagnostic Reasoning

Lorenzo Magnani, Giordano Lanzola, Mario Stefanelli, 1989, AIME.

Hybrid knowledge-based systems for therapy planning

Silvana Quaglini, Mario Stefanelli, Carlo Berzuini, 1992, Artif. Intell. Medicine.

A Blackboard Control Architecture for Therapy Planning

Riccardo Bellazzi, Silvana Quaglini, Mario Stefanelli, 1991, AIME.

An ontology-based framework for building economic evaluation models in health care

Silvana Quaglini, Mario Stefanelli, Sabina Falasconi, 1996 .

Deciding when to intervene: a Markov decision process approach

Silvana Quaglini, Paolo Magni, Giovanni Barosi, 2000, Int. J. Medical Informatics.

Optimal age and strategy for screening hereditary hemochromatosis. The answers from a Markov decision process

Silvana Quaglini, Paolo Magni, Giovanni Barosi, 1999 .

An epistemological framework for medical knowledge-based systems

M. Ramoni, Mario Stefanelli, Giovanni Barosi, 1992, IEEE Trans. Syst. Man Cybern..

Coherent Handling of Uncertainty via Localized Computation in an Expert System for Therapeutic Decision

Carlo Berzuini, Giovanni Barosi, G Polino, 1987 .

An Expert System for Anemia Diagnosis

Silvana Quaglini, Mario Stefanelli, Giovanni Barosi, 1986 .

Modelling of Diagnostic Reasoning

Lorenzo Magnani, Giordano Lanzola, Mario Stefanelli, 1988 .

Therapy Planning by Combining Ai and Decision Theoretic Techniques

Riccardo Bellazzi, Silvana Quaglini, Mario Stefanelli, 1989, AIME.

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

Paola Guglielmelli, Giovanni Barosi, Roberto Marchioli, 2007, Blood.

Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms

Paola Guglielmelli, Torsten Haferlach, William Tapper, 2015, Nature Communications.

Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders

Maria Domenica Cappellini, Giovanni Barosi, Sante Tura, 2008, Haematologica.

Evaluating the Performance of Anemia

Silvana Quaglini, Mario Stefanelli, Giovanni Barosi, 1987 .

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

Francisco Cervantes, Giovanni Barosi, Viktoriya Stalbovskaya, 2012, The New England journal of medicine.

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

Paola Guglielmelli, Giovanni Barosi, Carmine Tinelli, 2007, Blood.

Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease‐Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1)

Francesco Mannelli, Paola Guglielmelli, Giovanni Barosi, 2007, Stem cells.

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT).

Francisco Cervantes, Giovanni Barosi, Juergen Thiele, 2007, Leukemia research.

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.

Francisco Cervantes, Giovanni Barosi, Juergen Thiele, 2013, Blood.